Avacta Group (LON:AVCT) Shares Pass Below Two Hundred Day Moving Average – What’s Next?

Avacta Group Plc (LON:AVCT) passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of GBX 59.32 and traded as low as GBX 54. Avacta Group shares last traded at GBX 54.55, with a volume of 1,327,316 shares.

Wall Street Analysts Forecast Growth

Separately, Peel Hunt reiterated a “buy” rating and set a GBX 99 price objective on shares of Avacta Group in a report on Monday, October 13th. One research analyst has rated the stock with a Buy rating, Based on data from MarketBeat, the stock has a consensus rating of “Buy” and a consensus target price of GBX 99.

Avacta Group Price Performance

The business has a 50-day moving average price of GBX 68.78 and a two-hundred day moving average price of GBX 59.32. The company has a quick ratio of 4.96, a current ratio of 1.29 and a debt-to-equity ratio of 52.53. The company has a market capitalization of £236.58 million, a price-to-earnings ratio of -3.11 and a beta of 1.12.

Avacta Group Company Profile

Avacta Therapeutics is a clinical stage biopharmaceutical company challenging current drug delivery methods to expand the utility of highly potent cancer therapeutics.
The Company benefits from a world class research and development facility, team of exceptionally talented scientists and a highly experienced management team with members located in both the London headquarters and the US.

Our proprietary pre|CISION® platform masks toxic warheads by binding them to a short, engineered peptide that is cleavable only by the tumor-specific protease, fibroblast activation protein (FAP).